Search

everythinglearnresearchcommunity

for

Search:↓

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Non-surgical treatments like thread lifts, PRP therapy, HIFU, and radiofrequency effectively rejuvenate and tighten facial skin.

Old neuropharmacological drugs might be effective for treating inflammatory skin diseases.

Different treatments for PCOS focus on the specific symptoms, with weight loss and lifestyle changes being important.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Both platelet-rich plasma and low-level laser therapy effectively treat hair loss with minimal side effects and good cost-benefit ratio.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Shampoo with heat-killed Lacticaseibacillus paracasei GMNL-653 improves scalp health and hair growth by changing scalp bacteria.

Neurotoxins can affect neurotransmitter release and have potential in treating muscle, pain, and cancer conditions, but more research is needed on how they work.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

The document's conclusion cannot be provided because the document is not accessible or understandable.

The Polish medical societies have redefined metabolic syndrome and recommend lifestyle changes, certain medications, and possibly bariatric surgery for treatment. They also discuss managing related health conditions.

Methotrexate with corticosteroids can effectively treat severe alopecia areata but often requires long-term maintenance.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

People with severe Alopecia Areata have higher levels of TGF-β1, which may play a role in the condition.

High-dose corticosteroids and methotrexate had a modest effect on severe childhood alopecia, but side effects and relapse were concerns.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

A horse with severe hair loss was diagnosed with alopecia areata and a yeast infection.

Minoxidil injections can speed up hair regrowth in non-severe patchy hair loss, but combining it with steroids doesn't improve results.

Alopecia areata can be managed with various treatments, and severe cases should be referred to dermatologists.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Methotrexate is a promising and safe treatment for severe alopecia areata, with better results when combined with corticosteroids.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Hair and serum levels of zinc, copper, and iron are similar in people with alopecia areata and healthy individuals.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.